Zepbound may not be as widely known as its competitors, but the weight-loss drug may soon be more accessible than the rest.
US pharmaceutical giant Eli Lilly announced Wednesday that it will build four additional new manufacturing sites in the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback